Clinical guidelines for treatment of low back pain "Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association." Published in 2012.
The 10-question Alcohol Use Disorders Identification Test (AUDIT) was developed by the World Health Organization (WHO) specifically for primary care settings as a screen for detecting at-risk or hazardous drinking. A shorter version of the AUDIT also is used in primary care and consists of the first 3 questions of the AUDIT.
1. How often do you have a drink containing alcohol?
___ never (0 point)
___ less than monthly / monthly (1 point)
___ 2-4 times/month (2 points)
___ 2-3 times/week (3 points)
The ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, Second Edition-Revised (Mee-Lee et al., 2001) lists the 5 basic levels of care available for adult substance users. These levels of care range from Early Intervention (for at-risk individuals) to Medically Managed Intensive Inpatient Treatment (for patients with severe disorders who require around-the-clock care). The Patient Placement Criteria classifies opioid maintenance therapy as a Level I treatment since it is most often conducted in outpatient settings.
According to the Patient Placement Criteria, the following 6 patient dimensions should be considered when formulating a treatment plan (Mee-Lee et al., 2001):
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Interactive training is delivered by the FAOS DLearning System and requires IE 10/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
developed & maintained by
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.
Module development and evaluation has been funded solely through learner fees and funding from the NIH including: Buprenorphine Medical Student Education (#R44-DA12066), Medical Student Education on Alcohol Abuse and Dependence (#1R44AA016724-01A1), Ethical, Legal, and Social Issues (ELSI) Associated with Genetics (#R25-HG02266), Tobacco Cessation Web Based Modules for AHEC Students (Grant #R44HL65885), and Medical Student Pain Education (Grant #1R44DA027245-01). The website and Clinical Tools receive no support from the pharmaceutical or device manufacturing industries.